Smallpox Vaccination: Are American Children Still Getting It?

are children in usa still vaccinated for smallpox

Smallpox is an acute, contagious, and sometimes fatal disease caused by the variola virus. It has been eradicated thanks to a vaccine, which was first developed in the late 1700s. The last natural outbreak of smallpox in the United States happened in 1949. Routine smallpox vaccination in the United States ended in 1972, and the World Health Organization (WHO) declared smallpox eliminated in 1980. Today, the smallpox vaccine is no longer available to the public, and the Advisory Committee on Immunization Practices (ACIP) advises against non-emergency use of the vaccine in children younger than 18 years of age. However, the United States maintains a supply of smallpox vaccines in case of an outbreak.

Characteristics Values
Current vaccination status of children in the USA Routine smallpox vaccination in the USA was discontinued in 1972. The Advisory Committee on Immunization Practices (ACIP) advises against non-emergency use of smallpox vaccine in children younger than 18 years of age.
History of smallpox vaccination in children in the USA A different version of the smallpox vaccine was routinely given to all children in the USA at about 1 year of age. By the 1960s, the risk of smallpox in the USA had decreased significantly.
Reasons for discontinuation The risks of the vaccine outweighed its benefits.
Current at-risk groups Lab workers who work with related viruses, some military personnel, and healthcare and public health workers in the event of a smallpox outbreak
Current vaccine availability The smallpox vaccine is no longer available to the public. The United States has a supply of smallpox vaccines available in case of an outbreak.
Effectiveness of the vaccine Studies show that the vaccine is effective for 3 to 5 years.
Alternative treatments There is no proven treatment for smallpox, but research to evaluate new antiviral agents is ongoing. Vaccinia Immune Globulin (VIG) and cidofovir can help manage reactions to the smallpox vaccine.

cyvaccine

Smallpox vaccine history in the USA

Smallpox is a deadly disease caused by the variola virus. It is characterised by a fever and a progressive skin rash. It is highly contagious and has resulted in millions of deaths. It is also the only human disease to have been eradicated, thanks to vaccination.

The smallpox vaccine was the first vaccine to be developed against a contagious disease. In 1796, British physician Edward Jenner demonstrated that infection with the mild cowpox virus conferred immunity against smallpox. This was the world's first vaccine. The vaccine was developed using matter from a cowpox sore on the hand of a milkmaid, which was then administered to an 8-year-old boy, James Phipps. Phipps felt unwell for several days but made a full recovery. Two months later, Jenner inoculated Phipps with matter from a human smallpox sore, and the boy was in perfect health, becoming the first person to be vaccinated against smallpox.

In the 1840s and 1850s, mandatory smallpox vaccination was implemented in parts of the United States and other countries. The vaccine was transmitted from one person to another through arm-to-arm vaccination. In the 1880s, the calf lymph vaccine became the leading smallpox vaccine.

In the 1950s to 1970s, first-generation smallpox vaccines, grown on the skin of live animals, were widely distributed. The World Health Organization (WHO) conducted a global vaccination campaign during this period, which led to the eradication of smallpox. The campaign was aided by the development of the bifurcated needle by American microbiologist Benjamin Rubin in the 1960s, which was used to administer vaccines.

Routine smallpox vaccination in the United States ended in 1972. The last natural outbreak of smallpox in the country occurred in 1949. In 1980, the World Health Assembly declared smallpox completely eradicated.

Today, the smallpox vaccine is no longer available to the general public. However, it is still being produced for research and to guard against potential bioterrorism and biological warfare. The United States maintains a supply of the vaccine in case of an outbreak.

cyvaccine

Smallpox vaccination in children under 1

Smallpox is an acute, contagious, and sometimes fatal disease caused by the variola virus, a type of orthopoxvirus. The illness is characterised by a fever and a distinctive progressive skin rash. It is highly contagious, spreading from person to person through infected droplets of saliva, for example, when people cough or sneeze. It can also spread via contact with the rash or items that have touched the rash, such as clothing or bedding.

The smallpox vaccine was first developed in the late 1700s and was brought to the United States in 1799. The vaccine was created to protect against smallpox infection and works by helping the body develop immunity to the smallpox virus. The vaccine is made from a related virus called vaccinia, which infects cows (cowpox). The cowpox virus rarely causes disease in humans but can protect people from smallpox due to the similarities between the two viruses. The smallpox vaccine was successful in eradicating smallpox, and the disease was declared eliminated by the World Health Organization (WHO) in 1980.

In the United States, routine smallpox vaccination ended in 1972, and the vaccine is no longer available to the general public. Today, the smallpox vaccine is only recommended for a small number of people, such as laboratory workers handling the virus and some military personnel, due to the potential use of smallpox as a bioterrorism weapon.

Regarding children under the age of 1, there have been differing opinions on the timing of smallpox vaccination. Historically, a different version of the smallpox vaccine was routinely given to all children in the United States around the age of 1. However, due to the reduced risk of smallpox in the 1960s, the routine administration of the smallpox vaccine to infants was discontinued in 1972. The Advisory Committee on Immunization Practices (ACIP) currently advises against the non-emergency use of the smallpox vaccine in individuals younger than 12 months of age and children younger than 18 years of age.

Some arguments have been made for vaccinating children under 1 year of age to ensure they receive the benefit of smallpox vaccination, especially in large cities, where families may not return for subsequent clinic visits. However, reviews of smallpox vaccination complications in England, Wales, and the United States showed that dermal complications, particularly generalized vaccinia, occurred two to three times more frequently in children vaccinated before their first birthday compared to other age groups. As a result, the American Academy of Pediatrics Committee on the Control of Infectious Diseases and the Public Health Service Advisory Committee on Immunization Practices have recommended deferring primary smallpox vaccination until after the first birthday.

cyvaccine

Smallpox vaccination side effects

Smallpox is a serious, contagious, and sometimes fatal disease caused by the variola virus. It is characterised by a fever and a progressive skin rash. The last natural outbreak of smallpox in the United States occurred in 1949, and the last natural case of smallpox in the world was recorded in 1977. Subsequently, in 1980, the World Health Organization (WHO) recommended that all countries stop vaccinating for smallpox, declaring the disease eradicated.

Routine smallpox vaccination in the United States ended in 1972, and the last vaccine produced using calf lymph was discontinued in 1982. The smallpox vaccine is no longer available to the public, and studies show that its effectiveness lasts for only 3 to 5 years. However, the United States maintains a supply of smallpox vaccines in the event of an outbreak, which is deemed unlikely.

The smallpox vaccine is highly effective in preventing smallpox infection. It helps the body develop immunity to the smallpox virus without containing a weakened or killed form of the virus. While the vaccine is generally safe and effective for most people, certain side effects have been observed, ranging from mild and self-limiting to severe and life-threatening.

The most common side effects are typically mild and include a sore and red arm at the vaccination site, swollen and sore lymph nodes in the armpits, and a slight fever. Additionally, about one-third of vaccinated individuals may experience fatigue, sleep disturbances, or other generalised discomfort. These side effects usually resolve without treatment and indicate that the vaccine is working.

In rare cases, more severe side effects may occur, including toxic or allergic rashes, such as erythema multiforme. Some individuals with weakened immune systems or certain skin conditions, such as eczema or atopica dermatitis, may develop serious skin rashes like eczema vaccinatum or progressive vaccinia, which can lead to tissue destruction and death. Postvaccinal encephalitis, or inflammation of the brain, has also been reported. It is estimated that one to two people out of every million vaccinated may die from life-threatening reactions to the vaccine.

Furthermore, there have been reports of heart-related issues, including heart pain (angina), myocarditis (heart inflammation), pericarditis (inflammation of the membrane covering the heart), and myopericarditis (a combination of myocarditis and pericarditis).

It is important to note that the risk of serious side effects is higher in individuals with specific medical conditions, such as weakened immune systems or certain skin conditions. These individuals should generally avoid the smallpox vaccine unless they have been exposed to smallpox. In the event of serious reactions, treatments such as Vaccinia Immune Globulin (VIG) and cidofovir can be used to manage them.

cyvaccine

Smallpox vaccine availability

Smallpox is an acute, often fatal, and highly contagious disease caused by the variola virus, a type of orthopoxvirus. The last natural outbreak of smallpox in the United States occurred in 1949, and the last naturally occurring case of smallpox worldwide happened in 1977. The World Health Organization (WHO) declared smallpox eradicated in 1980.

The smallpox vaccine was created to protect against smallpox infection and was successful in eradicating the disease. The vaccine is made from a related virus called vaccinia, which infects cows (cowpox). The smallpox vaccine does not contain a weakened or killed form of the variola virus and cannot cause smallpox. The vaccine is administered by placing a drop of the vaccinia virus on the upper arm and then puncturing the skin multiple times with a needle to inoculate the virus into the body.

In the United States, routine smallpox vaccination ended in 1972 due to the low risk of smallpox and the potential side effects of the vaccine. The Advisory Committee on Immunization Practices (ACIP) advises against non-emergency use of the smallpox vaccine in children under 18 years of age and individuals younger than 12 months of age. The vaccine is also not recommended for geriatric populations, generally considered those 65 and older, unless they have been exposed to smallpox.

Currently, the smallpox vaccine is not available to the general public. However, the United States maintains a supply of smallpox vaccines in case of an outbreak. Vaccination is recommended for specific groups, such as some lab workers handling related viruses, military personnel due to the potential use of smallpox as a biological weapon, and healthcare workers responding to a potential outbreak.

While the risk of smallpox exposure is very low, the smallpox vaccine is still relevant due to its potential use in responding to outbreaks or bioterrorism threats.

cyvaccine

Smallpox as a bioterrorism weapon

Smallpox is an acute, contagious, and sometimes fatal disease caused by the variola virus, a type of orthopoxvirus. It is characterised by a fever and a distinctive progressive skin rash. The last natural outbreak of smallpox in the United States occurred in 1949, and the last natural case of smallpox in the world was in 1977. The World Health Organization (WHO) declared smallpox eradicated in 1980, thanks to a vaccine created by Edward Jenner in the late 18th century.

Despite its eradication, smallpox remains a potential agent of bioterrorism. Smallpox has been used as a biological weapon for centuries, with the earliest known example dating back to the 14th century when Tartar forces catapulted the corpses of smallpox victims into besieged towns. More recently, in 2001, allegations emerged that Iran had weaponised smallpox, and there were also unproven claims that France, Iraq, North Korea, and Yemen possessed the virus.

The possibility of smallpox being released in aerosolised form is a serious threat, with the potential for catastrophic consequences. Smallpox is classified as a Category A organism by the Centers for Disease Control and Prevention (CDC), indicating that it is easily disseminated, transmitted from person to person, and can result in high mortality rates. A bioterrorist attack using smallpox could lead to a complete or partial disruption of vital activities, a shortage of medical personnel, and extreme panic among the public.

To prevent and mitigate the impact of a potential bioterrorist attack using smallpox, reliable intelligence is crucial. Knowing the location of the virus and the intentions of its possessors is essential for preventive efforts. In addition, the development of effective detection systems, quarantine and isolation procedures, vaccine prophylaxis, and appropriate therapies for early and late-stage infections are vital components of preparedness.

In the United States, efforts have been made to enhance preparedness for a potential smallpox attack. A nationwide smallpox preparedness program has been established, which includes the vaccination of healthcare and public health workers who would be responsible for responding to an outbreak. The Advisory Committee on Immunization Practices (ACIP) has recommended that preventive vaccination programs should focus on protecting first-line responders, including emergency and key healthcare personnel and law enforcement.

While the threat of smallpox as a bioterrorism weapon is real, it is important to note that most biodefence experts consider a smallpox terrorist attack to be unlikely. The widespread availability of vaccines and the difficulty in manufacturing large quantities of the smallpox virus contribute to the low likelihood of smallpox being utilised as a bioterrorism weapon.

Frequently asked questions

No, routine smallpox vaccination in the United States ended in 1972.

By the 1960s, the risk of smallpox in the United States was dramatically reduced. Therefore, the risks of the vaccine outweighed its benefits.

Smallpox has been eradicated worldwide, and the virus only exists in samples in heavily guarded research laboratories. However, the United States has a supply of smallpox vaccines in case of an outbreak. Smallpox has been considered a potential weapon in a bioterrorist attack.

The Advisory Committee on Immunization Practices (ACIP) advises against non-emergency use of the smallpox vaccine in children younger than 18 years of age. The American Academy of Pediatrics Committee on the Control of Infectious Diseases recommends that primary smallpox vaccination be deferred until after the first birthday.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment